REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/01/2025
Back to search
Official data from USPTO
GENOMIC BIOPSY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENOMIC BIOPSY
ST13
US500000088175175Class
44
Filing
88175175
Registration
6213175
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
12/02/2025
Trademark type
Word
Nice classes
44
Filing date
10/30/2018
Registration date
12/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2020
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2018-12-00
First use in commerce
2018-12-00
Drawing code
4
Owner type
03
Owner location
San Diego, CA
Examiner
CLARKE, NANCY
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Vivid Genomics, Inc.
Representatives
James M. Duncan Scanlon Duncan LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing DNA screening for medical purposes in the nature of blood-basedgenetic tests for early detection of neurodegenerative disorders for the purpose of enabling physicians and/or pharmaceutical companies to identify appropriate drug therapies
Publications
History of USPTO decisions and trademark events.
35 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/01/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/27/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10/20/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2020
GNRT
NON-FINAL ACTION E-MAILED
04/08/2020
CNRT
NON-FINAL ACTION WRITTEN
04/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2020
ALIE
ASSIGNED TO LIE
03/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/29/2020
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
02/13/2020
IUAA
USE AMENDMENT ACCEPTED
02/12/2020
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/07/2020
IUAF
USE AMENDMENT FILED
02/07/2020
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/05/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/18/2019
GNRT
NON-FINAL ACTION E-MAILED
09/18/2019
CNRT
NON-FINAL ACTION WRITTEN
09/18/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2019
GNRT
NON-FINAL ACTION E-MAILED
02/13/2019
CNRT
NON-FINAL ACTION WRITTEN
02/13/2019
DOCK
ASSIGNED TO EXAMINER
02/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/15/2018
NWAP
NEW APPLICATION ENTERED
11/02/2018
Continuous trademark protection
Get notified about every new filing that threatens GENOMIC BIOPSY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.